Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
| US Infectious Disease Molecular Diagnostics Market 2021: Supplier Shares by Test, Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation Review | ||
| By: PR Newswire Association LLC. - 22 Nov 2017 | Back to overview list |
|
LONDON, Nov. 22, 2017 /PRNewswire/ -- Complete report $6,200. DataPack (test volumes, sales forecasts, supplier shares) $3,900. The report is available by section, market segment, individual test, and can be custom-tailored to your specific information needs and budget.
This new study from VPGMarketResearch.com contains 1,013 pages, 62 tables, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the infectious disease molecular diagnostics market during the next five years. Report Highlights - Business and technological trends in major markets Rationale The infectious disease molecular diagnostics market is one of the most rapidly growing segment of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods. In order to successfully capitalize on the opportunities presented by the infectious disease molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next five years. US Market Overview - Laboratories performing DNA sequencing and molecular diagnostic testing for infectious diseases - Five-year test volume and sales projections. Market Segmentation Analysis - Sales and market shares of leading suppliers of infectious disease molecular diagnostic - Five-year test volume and sales projections for over 40 infectious disease molecular diagnostic assays. - A comprehensive analysis of the sequencing market by country and laboratory segment. Product/Technology Review - Comparison of leading infectious disease molecular diagnostic analyzers. - Extensive review of molecular diagnostic technologies, test formats, detection methodologies, - Worldwide listings of companies, universities and research centers developing new molecular Competitive Assessments - Extensive strategic assessments of major suppliers and emerging market entrants, - Comprehensive listings of companies developing and marketing infectious disease molecular Opportunities and Strategic Recommendations - Specific new product development opportunities with potentially significant market appeal - Design criteria for new products. Contains 1,013 pages and 62 tables
SOURCE ReportBuyer 
|
||
|
|
||
 | Back to overview list | |